Dimensional Fund Advisors’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.7M Buy
1,128,465
+255,327
+29% +$2.44M ﹤0.01% 2274
2026
Q1
$7.97M Buy
873,138
+107,930
+14% +$905K ﹤0.01% 2337
2025
Q4
$5.69M Buy
765,208
+21,777
+3% +$157K ﹤0.01% 2489
2025
Q3
$4.97M Buy
743,431
+71,624
+11% +$497K ﹤0.01% 2547
2025
Q2
$4.45M Buy
671,807
+150,070
+29% +$1.06M ﹤0.01% 2560
2025
Q1
$4.77M Buy
521,737
+94,315
+22% +$942K ﹤0.01% 2507
2024
Q4
$4.49M Buy
427,422
+152,311
+55% +$1.8M ﹤0.01% 2566
2024
Q3
$3.29M Buy
275,111
+157,615
+134% +$1.36M ﹤0.01% 2657
2024
Q2
$676K Buy
117,496
+58,954
+101% +$323K ﹤0.01% 2978
2024
Q1
$304K Buy
58,542
+27,686
+90% +$135K ﹤0.01% 3133
2023
Q4
$163K Buy
30,856
+10,978
+55% +$43.4K ﹤0.01% 3222
2023
Q3
$65.6K Buy
19,878
+20
+0.1% +$70 ﹤0.01% 3363
2023
Q2
$57.4K Sell
19,858
-459
-2% -$881 ﹤0.01% 3393
2023
Q1
$21.7K Buy
+20,317
New +$38.9K ﹤0.01% 3433
2022
Q3
$267K Sell
38,149
-1,260
-3% -$9.87K ﹤0.01% 3185
2022
Q2
$269K Buy
+39,409
New +$402K ﹤0.01% 3200

Other funds holding BVS

Dimensional Fund Advisors's BVS Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Bioventus (BVS) stake by 29% in Q2 2026, buying an estimated $2.44M and bringing the position to 1,128,465 shares worth $10.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2274.

Dimensional Fund Advisors first reported a position in BVS in Q2 2022 and has held it in 16 quarters since. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Dimensional Fund Advisors held 1,128,465 shares of Bioventus worth $10.7M as of Q2 2026.
  • Dimensional Fund Advisors bought 255,327 Bioventus shares in Q2 2026, an estimated $2.44M.
  • Bioventus made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2274 holding.
  • Dimensional Fund Advisors first reported a position in Bioventus in Q2 2022 and has held it in 16 quarters since.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.